PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
126 hedge funds and large institutions have $518M invested in Progenics Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
Holders
126
Holding in Top 10
1
Calls
$2.19M
Puts
$1.05M
Top Buyers
| 1 | +$23M | |
| 2 | +$5.97M | |
| 3 | +$4.15M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.42M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.11M |
Top Sellers
| 1 | -$18M | |
| 2 | -$5.78M | |
| 3 | -$4.4M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$4.32M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$3.25M |